ASIC1a Inhibitor mambalgin-2 Suppresses the Growth of Leukemia Cells by Cell Cycle Arrest

Although tyrosine kinase inhibitors have brought significant success in the treatment of chronic myelogenous leukemia, the search for novel molecular targets for the treatment of this disease remains relevant. Earlier, expression of acid-sensing ion channels, ASIC1a, was demonstrated in the chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bychkov, M. L., Shulepko, M. A., Vasileva, V. Y., Sudarikova, A. V., Kirpichnikov, M. P., Lyukmanova, E. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385094/
https://www.ncbi.nlm.nih.gov/pubmed/32742733
http://dx.doi.org/10.32607/actanaturae.10949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385094/
https://www.ncbi.nlm.nih.gov/pubmed/32742733
http://dx.doi.org/10.32607/actanaturae.10949

Ejemplares similares